2008
DOI: 10.1016/j.carrev.2007.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Coronary stenting with MGuard: from conception to human trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0
1

Year Published

2009
2009
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 37 publications
0
16
0
1
Order By: Relevance
“…These characteristics make this device very attractive for any intervention where thromboembolic complications might affect procedural and clinical success, such as PCI in STEMI setting. In fact, animal and human studies showed that this new device is safe [11,12] and could be useful for patients with a great amount of coronary thrombus [13][14][15].…”
Section: Introductionmentioning
confidence: 97%
“…These characteristics make this device very attractive for any intervention where thromboembolic complications might affect procedural and clinical success, such as PCI in STEMI setting. In fact, animal and human studies showed that this new device is safe [11,12] and could be useful for patients with a great amount of coronary thrombus [13][14][15].…”
Section: Introductionmentioning
confidence: 97%
“…1, 2 The MGuard™ stent (InspireMD, Tel Aviv, Israel) is a novel mesh-covered stent that has been designed to prevent thrombus fragmentation and distal embolization during stent implantation. 3 Although the MGuard stent has been shown to be safe and effective in consecutive patients with STEMI, its use in selected patients with persistent high thrombus burden after thrombus aspiration has not been described.…”
Section: Introductionmentioning
confidence: 99%
“…During stent deployment, this biocompatible micronet stretches and slides over the expanded stent struts resulting in the formation of customized pores [24], thereby potentially entrapping thrombus and plaque fragments underneath the micronet against the vessel wall. This feature may lead to prevention of distal embolization and microcirculatory protection in the acute setting of STEMI.…”
Section: Microcirculatory Protectionmentioning
confidence: 99%